Viridian Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FMR LLC | 08/14/2025 | 12.24 M | $171.10 M | 0.13% | 15.00% |
BLACKROCK, INC. | 08/12/2025 | 5.52 M | $77.18 M | -3.28% | 6.77% |
DEEP TRACK CAPITAL, LP | 08/14/2025 | 5.38 M | $75.22 M | 0.00% | 6.59% |
COMMODORE CAPITAL LP | 08/14/2025 | 4.88 M | $68.15 M | 35.42% | 5.97% |
VANGUARD GROUP INC | 08/11/2025 | 4.51 M | $63.03 M | -1.20% | 5.53% |
KYNAM CAPITAL MANAGEMENT, LP | 08/14/2025 | 4.43 M | $61.90 M | -5.79% | 5.43% |
VR ADVISER, LLC | 08/14/2025 | 3.88 M | $54.28 M | 0.00% | 4.76% |
FAIRMOUNT FUNDS MANAGEMENT LLC | 08/14/2025 | 3.46 M | $48.37 M | 0.41% | 4.24% |
PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2025 | 2.90 M | $40.48 M | 71.51% | 3.55% |
TANG CAPITAL MANAGEMENT LLC | 08/14/2025 | 2.84 M | $39.74 M | 1.79% | 3.48% |
PARADIGM BIOCAPITAL ADVISORS LP | 08/14/2025 | 2.74 M | $38.33 M | 30.86% | 3.36% |
STATE STREET CORP | 08/14/2025 | 2.55 M | $35.70 M | -10.89% | 3.13% |
NOVO HOLDINGS A/S | 08/14/2025 | 2.38 M | $33.27 M | 5.76% | 2.92% |
MAVERICK CAPITAL LTD | 08/14/2025 | 2.26 M | $31.55 M | 9.50% | 2.77% |
ALLIANCEBERNSTEIN L.P. | 08/14/2025 | 1.94 M | $27.18 M | -3.84% | 2.38% |
EVERSEPT PARTNERS, LP | 08/14/2025 | 1.90 M | $26.60 M | 38.10% | 2.33% |
BAKER BROS. ADVISORS LP | 08/14/2025 | 1.74 M | $24.39 M | 100.00% | 2.14% |
GEODE CAPITAL MANAGEMENT, LLC | 08/08/2025 | 1.74 M | $24.34 M | 1.17% | 2.13% |
LOOMIS SAYLES & CO L P | 08/13/2025 | 1.34 M | $18.71 M | -2.33% | 1.64% |
PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2025 | 1.30 M | $18.16 M | 22.01% | 1.59% |
PICTET ASSET MANAGEMENT HOLDING SA | 08/13/2025 | 1.27 M | $17.70 M | 1.36% | 1.55% |
MARSHALL WACE, LLP | 08/13/2025 | 1.21 M | $16.89 M | 11.42% | 1.48% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2025 | 1.11 M | $15.50 M | -0.54% | 1.36% |
VIVO CAPITAL, LLC | 08/14/2025 | 982.58 K | $13.74 M | 0.00% | 1.20% |
GOLDMAN SACHS GROUP INC | 08/14/2025 | 899.83 K | $12.58 M | -26.91% | 1.10% |
CANDRIAM S.C.A. | 08/08/2025 | 862.27 K | $12.06 M | -2.06% | 1.06% |
WOODLINE PARTNERS LP | 08/14/2025 | 815.49 K | $11.40 M | 0.23% | 1.00% |
5AM VENTURE MANAGEMENT, LLC | 08/14/2025 | 736.60 K | $10.30 M | 0.00% | 0.90% |
ROSALIND ADVISORS, INC. | 08/14/2025 | 700.00 K | $9.79 M | 17.65% | 0.86% |
CITADEL ADVISORS LLC | 08/14/2025 | 649.54 K | $9.08 M | 633.56% | 0.80% |
NORTHERN TRUST CORP | 08/13/2025 | 596.88 K | $8.34 M | -15.04% | 0.73% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2025 | 574.02 K | $8.02 M | 1.42% | 0.70% |
VICTORY CAPITAL MANAGEMENT INC | 08/13/2025 | 564.79 K | $7.90 M | 2.16% | 0.69% |
UBS GROUP AG | 08/14/2025 | 533.64 K | $7.46 M | 5.84% | 0.65% |
RICE HALL JAMES & ASSOCIATES, LLC | 08/11/2025 | 515.62 K | $7.21 M | 42.09% | 0.63% |
FISHER ASSET MANAGEMENT, LLC | 08/13/2025 | 509.96 K | $7.13 M | -5.04% | 0.63% |
YIHENG CAPITAL MANAGEMENT, L.P. | 08/14/2025 | 500.26 K | $6.99 M | 0.00% | 0.61% |
DIMENSIONAL FUND ADVISORS LP | 08/12/2025 | 485.70 K | $6.79 M | 100.00% | 0.60% |
HIGHVISTA STRATEGIES LLC | 08/14/2025 | 484.56 K | $6.77 M | 168.38% | 0.59% |
IKARIAN CAPITAL, LLC | 08/14/2025 | 469.95 K | $6.57 M | -5.05% | 0.58% |
PERCEPTIVE ADVISORS LLC | 08/14/2025 | 447.51 K | $6.26 M | -32.16% | 0.55% |
NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 07/25/2025 | 423.27 K | $5.92 M | 0.00% | 0.52% |
JPMORGAN CHASE & CO | 08/12/2025 | 415.99 K | $5.82 M | 39.34% | 0.51% |
AFFINITY ASSET ADVISORS, LLC | 08/13/2025 | 390.00 K | $5.45 M | 0.00% | 0.48% |
DEUTSCHE BANK AG\ | 08/12/2025 | 386.94 K | $5.41 M | -2.49% | 0.47% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 08/14/2025 | 376.85 K | $5.27 M | -70.34% | 0.46% |
PANAGORA ASSET MANAGEMENT INC | 08/13/2025 | 351.85 K | $4.92 M | -0.81% | 0.43% |
ROYAL BANK OF CANADA | 08/14/2025 | 345.90 K | $4.84 M | 162,293.43% | 0.42% |
RAYMOND JAMES FINANCIAL INC | 08/14/2025 | 332.09 K | $4.64 M | 4.35% | 0.41% |
WELLINGTON MANAGEMENT GROUP LLP | 08/14/2025 | 270.54 K | $3.78 M | 8.58% | 0.33% |
Viridian Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 215 institutional investors and hedge funds held shares of Viridian Therapeutics, Inc.. The most heavily invested institutionals were:
FMR LLC: 12.24 M
BlackRock, Inc.: 5.52 M
Deep Track Capital, LP: 5.38 M
COMMODORE CAPITAL LP: 4.88 M
VANGUARD GROUP INC: 4.51 M
Kynam Capital Management, LP: 4.43 M
115.89% of Viridian Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 101.98 M shares in the last 24 months. This purchase volume represents approximately $2.02 B in transactions.